5-hydroxytryptophan has been researched along with buspirone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Itoh, Y; Oishi, R; Saeki, K | 1 |
Brokaw, JJ; Hausz, JA; Matheson, GK; Tunnicliff, G; White, GW | 1 |
Bohmaker, K; Goldstein, M; Meller, E | 1 |
Engel, JA; Hjorth, S; Söderpalm, B | 1 |
Mitchell, SN; Thomas, PJ | 1 |
Maes, M; Meltzer, HY; Thompson, PA | 1 |
Kitamura, Y; Nagatani, T; Watanabe, T | 1 |
Esteban, S; García-Sevilla, JA; Miralles, A; Moranta, D; Sastre-Coll, A | 1 |
Liang, JH; Liu, RK; Sun, HL; Wang, XH; Ye, XF; Zheng, JW | 1 |
1 trial(s) available for 5-hydroxytryptophan and buspirone
Article | Year |
---|---|
Effect of the placebo control condition in neuroendocrine challenge studies.
Topics: 5-Hydroxytryptophan; Antipsychotic Agents; Apomorphine; Bias; Buspirone; Data Interpretation, Statistical; Depressive Disorder; Female; Fenfluramine; Growth Hormone; Humans; Hydrocortisone; Male; Prolactin; Pyrazines; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists | 1994 |
8 other study(ies) available for 5-hydroxytryptophan and buspirone
Article | Year |
---|---|
Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biotransformation; Brain; Buspirone; Histamine; Histamine Antagonists; Male; Methylhistamines; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes | 1992 |
Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Buspirone; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Female; Hydrazines; Rats; Rats, Sprague-Dawley; Serotonin | 1992 |
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Buspirone; Cerebral Cortex; Hippocampus; Male; Piperazines; Pyrimidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes | 1990 |
Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Buspirone; Conflict, Psychological; Male; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1989 |
Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Brain; Buspirone; Chlordiazepoxide; Chromatography, High Pressure Liquid; Hydrazines; Male; Rats; Rats, Inbred Strains; Restraint, Physical; Serotonin; Stress, Psychological; Time Factors | 1988 |
Buspirone enhances head twitch behavior in mice.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Buspirone; Drug Interactions; Male; Mice; Pargyline; Piperazines; Propranolol; Receptors, Serotonin; Serotonin Antagonists | 1994 |
Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Buspirone; Cerebral Cortex; Chronic Disease; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Ethanol; Hippocampus; Male; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2002 |
Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice.
Topics: 5-Hydroxytryptophan; Analgesics; Animals; Buspirone; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chloride; Central Nervous System Stimulants; Chelating Agents; Egtazic Acid; Female; Fluoxetine; Injections, Intraventricular; Mice; Nifedipine; Pain Measurement; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ryanodine; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2003 |